Company registration number 10700015 (England and Wales)
KALKI HEALTH LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2025
PAGES FOR FILING WITH REGISTRAR
KALKI HEALTH LIMITED
CONTENTS
Page
Balance sheet
1 - 2
Notes to the financial statements
3 - 7
KALKI HEALTH LIMITED
BALANCE SHEET
AS AT
30 SEPTEMBER 2025
30 September 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Intangible assets
3
1,343,734
1,400,882
Tangible assets
4
130,633
156,152
1,474,367
1,557,034
Current assets
Stocks
67,409
78,151
Debtors
5
833,230
360,316
Cash at bank and in hand
177,385
242,910
1,078,024
681,377
Creditors: amounts falling due within one year
6
(850,036)
(885,659)
Net current assets/(liabilities)
227,988
(204,282)
Total assets less current liabilities
1,702,355
1,352,752
Creditors: amounts falling due after more than one year
7
(1,420,242)
(1,087,503)
Provisions for liabilities
(23,965)
(28,436)
Net assets
258,148
236,813
Capital and reserves
Called up share capital
100
100
Profit and loss reserves
258,048
236,713
Total equity
258,148
236,813
KALKI HEALTH LIMITED
BALANCE SHEET (CONTINUED)
AS AT
30 SEPTEMBER 2025
30 September 2025
- 2 -
For the financial year ended 30 September 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true
The financial statements were approved by the board of directors and authorised for issue on 17 March 2026 and are signed on its behalf by:
Mr VM Bhatia
Director
Company registration number 10700015 (England and Wales)
KALKI HEALTH LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2025
- 3 -
1
Accounting policies
Company information
Kalki Health Limited is a private company limited by shares incorporated in England and Wales. The registered office is Elthorne Gate, 64 High Street, Pinner, Middlesex, HA5 5QA.
1.1
Basis of preparation
These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
The financial statements have been prepared under the historical cost convention, [modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value]. The principal accounting policies adopted are set out below.
1.2
Going concern
Atruet the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.
1.3
Revenue
Turnover represents revenue generated from the pharmacy and is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discount, settlement discounts and volume rebates.
1.4
Intangible fixed assets - goodwill
Positive goodwill is capitalised, classified as an asset on the balance sheet and amortised on a straight line basis over its useful economic life. It is reviewed for impairment at the end of the first full financial year following the acquisition and in other periods if events or changes in circumstances indicate that the carrying value may not be recoverable.
Goodwill, being the amount paid in connection with the acquisition of a business in 2017 and 2023, is being amortised evenly over its estimated useful life of thirty years.
1.5
Tangible fixed assets
Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.
Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:
Fixtures and fittings
20% on reducing balance
Computers
20% on reducing balance
Motor vehicles
20% on reducing balance
The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.
KALKI HEALTH LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 SEPTEMBER 2025
1
Accounting policies
(Continued)
- 4 -
1.6
Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items
1.7
Taxation
The tax expense represents the sum of the tax currently payable and deferred tax.
Current tax
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.
Current or deferred taxation assets and liabilities are not discounted.
Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.
Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.
Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.
The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.
1.8
Retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.
1.9
Leases
As lessee
Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessees. All other leases are classified as operating leases.
Assets held under finance leases are recognised as assets at the lower of the assets fair value at the date of inception and the present value of the minimum lease payments. The related liability is included in the balance sheet as a finance lease obligation. Lease payments are treated as consisting of capital and interest elements. The interest is charged to profit or loss so as to produce a constant periodic rate of interest on the remaining balance of the liability.
KALKI HEALTH LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 SEPTEMBER 2025
- 5 -
2
Employees
The average monthly number of persons (including directors) employed by the company during the year was:
2025
2024
Number
Number
Total
20
18
3
Intangible fixed assets
Goodwill
£
Cost
At 1 October 2024 and 30 September 2025
1,714,447
Amortisation and impairment
At 1 October 2024
313,565
Amortisation charged for the year
57,148
At 30 September 2025
370,713
Carrying amount
At 30 September 2025
1,343,734
At 30 September 2024
1,400,882
4
Tangible fixed assets
Fixtures and fittings
Computers
Motor vehicles
Total
£
£
£
£
Cost
At 1 October 2024
181,924
19,446
50,250
251,620
Additions
1,516
6,179
7,695
At 30 September 2025
183,440
25,625
50,250
259,315
Depreciation and impairment
At 1 October 2024
76,925
8,493
10,050
95,468
Depreciation charged in the year
21,748
3,426
8,040
33,214
At 30 September 2025
98,673
11,919
18,090
128,682
Carrying amount
At 30 September 2025
84,767
13,706
32,160
130,633
At 30 September 2024
104,999
10,953
40,200
156,152
KALKI HEALTH LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 SEPTEMBER 2025
4
Tangible fixed assets
(Continued)
- 6 -
Included within the net book value of the above asset is £32,160 relating to assets held under hire purchase agreements. The depreciation charged to the financial statements in the year in respect of such assets amounted to £8,040.
5
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
241,487
208,038
Other debtors
523,770
89,914
Prepayments and accrued income
67,973
62,364
833,230
360,316
6
Creditors: amounts falling due within one year
2025
2024
£
£
Bank loans
90,619
99,565
Trade creditors
389,146
399,303
Taxation and social security
40,264
41,600
Other creditors
330,007
345,191
850,036
885,659
7
Creditors: amounts falling due after more than one year
2025
2024
Notes
£
£
Bank loans and overdrafts
1,391,599
1,049,313
Obligations under finance leases
8
28,643
38,190
1,420,242
1,087,503
Creditors which fall due after five years are payable as follows:
Payable by instalments
1,055,806
661,137
Included in the bank loans due within one year and after one year is £1,475,547 secured by a fixed and floating charge over the assets of the company.
KALKI HEALTH LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 SEPTEMBER 2025
- 7 -
8
Finance lease obligations
2025
2024
Amounts due:
£
£
Within one year
9,548
9,548
After more than one year
28,643
38,190
38,191
47,738
2025
2024
Future minimum lease payments due under finance leases:
£
£
Within one year
9,548
9,548
In two to five years
28,643
38,190
38,191
47,738
The above disclosed hire purchase contract has a fixed interest rate and is secured over the asset held under hire purchase lease commitments.
9
Operating lease commitments
As lessee
At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, as follows:
2025
2024
£
£
Total commitments
231,920
266,328
10
Directors' transactions
During the year the company paid interest of £35,262 at 10% per annum on outstanding loan from the director.